 |
인쇄하기
취소
|
Domestic pharmaceutical firms concentrating on development of new anticancer therapies
Domestic pharmaceutical firms are focusing on new anticancer therapies for bolstering their crucial R&D capability, according to data compiled by the Korea Drug Research Association.
By therapeutic category, antineoplastic agents in the immunology represent more than 27 percent of 70-odd oncoming R&D projects in Korea, followed by antivirals and antibiotics. Currently, 19 promising anticance...
By therapeutic category, antineoplastic agents in the immunology represent more than 27 percent of 70-odd oncoming R&D projects in Korea, followed by antivirals and antibiotics. Currently, 19 promising anticance...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.